Furthermore, Marchetti et al. established that hyperglycemia-induced EPC damage can be reversed through the administration of benfotiamine via the modulation of PKB/Forkhead box protein O1 (FoxO1) activity [50]. This evidence concerns the gene FOXO1 and Hyperglycemia.